ATRA
Atara Biotherapeutics, Inc.
$9.76
-0.19 (-1.86%)
At close · Jul 10
Market Cap
$87.94M
Shares
9,010,172
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-22 | |
| 8-K | 2026-06-12 | 2026-06-09 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-05-01 | 2026-04-30 | |
| DEF 14A | 2026-04-24 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-23 | 2026-02-20 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-02 | 2025-12-30 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-07 | 2025-10-06 | |
| 8-K | 2025-09-04 | 2025-09-02 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-07-14 | — | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 8-K | 2025-05-16 | 2025-05-14 | |
| 8-K | 2025-05-15 | 2025-05-14 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-05-06 | 2025-05-05 | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 8-K | 2025-04-04 | 2025-03-31 | |
| 8-K | 2025-03-31 | 2025-03-25 | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-03-07 | — | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-01-27 | — | |
| 8-K | 2025-01-21 | — | |
| 8-K | 2025-01-16 | — | |
| 8-K | 2024-12-23 | 2024-12-20 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-08 | |
| 8-K | 2024-10-15 | 2024-10-14 | |
| 8-K | 2024-09-03 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | 2024-08-10 | |
| 8-K | 2024-07-17 | — | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-06-11 | 2024-06-10 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-26 | 2024-06-10 |
Showing 1–50 of 124 filings